Chuckowree, GB

Irina Chuckowree, Slough GB

Patent application number	Description	Published
20080242665	PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE - Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R	10-02-2008
20080269210	PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE - Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R	10-30-2008
20090118275	THIAZOLOPYRIMIDINE P13K INHIBITOR COMPOUNDS AND METHODS OF USE - Compounds of Formulas Ia and Ib, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.	05-07-2009

Patent application number	Description	Published
20080207609	Pharmaceutical compounds - Fused pyrimidines of formula (I):	08-28-2008
20080207611	Pharmaceutical compounds - Fused pyrimidines of formula (I):	08-28-2008
20100234370	PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I):	09-16-2010
20100280027	PHARMACEUTICAL COMPOUNDS - Provided herein are methods of treating diseases or disorders arising from abnormal cell growth, function or behavior associated with PI3 kinase, which method includes administering to a patient in need thereof a compound that is a fused pyrimidine of formula (I):	11-04-2010

Patent application number	Description	Published
20090209559	PHARMACEUTICAL COMPOUNDS - Fused pyrimidines of formula (I):	08-20-2009